药明康德|20天从申请到获批!FDA新试点项目加速抗癌药审评( 二 )


[2]NovartisKisqalinowfirstandonlyCDK4/6inhibitorindicatedinUSasfirst-linetherapyspecificallyforpremenopausalwomen;andasinitialtherapywithfulvestrantinpostmenopausalwomen


推荐阅读